<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25862818</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>194</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.</ArticleTitle><Pagination><StartPage>4737</StartPage><EndPage>4749</EndPage><MedlinePgn>4737-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.1402312</ELocationID><Abstract><AbstractText>Scavenger receptor class B, member 2 (SCARB2) is essential for endosome biogenesis and reorganization and serves as a receptor for both &#x3b2;-glucocerebrosidase and enterovirus 71. However, little is known about its function in innate immune cells. In this study, we show that, among human peripheral blood cells, SCARB2 is most highly expressed in plasmacytoid dendritic cells (pDCs), and its expression is further upregulated by CpG oligodeoxynucleotide stimulation. Knockdown of SCARB2 in pDC cell line GEN2.2 dramatically reduces CpG-induced type I IFN production. Detailed studies reveal that SCARB2 localizes in late endosome/lysosome of pDCs, and knockdown of SCARB2 does not affect CpG oligodeoxynucleotide uptake but results in the retention of TLR9 in the endoplasmic reticulum and an impaired nuclear translocation of IFN regulatory factor 7. The IFN-I production by TLR7 ligand stimulation is also impaired by SCARB2 knockdown. However, SCARB2 is not essential for influenza virus or HSV-induced IFN-I production. These findings suggest that SCARB2 regulates TLR9-dependent IFN-I production of pDCs by mediating endosomal translocation of TLR9 and nuclear translocation of IFN regulatory factor 7.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jialong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanbing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haisheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Xiangyun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Peishuang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plumas</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Etablissement Fran&#xe7;ais du Sang Rh&#xf4;ne-Alpes Grenoble, La Tronche 38701, France;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaperot</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Etablissement Fran&#xe7;ais du Sang Rh&#xf4;ne-Alpes Grenoble, La Tronche 38701, France;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianzhu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Lishan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yongjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, TX 75204.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liguo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; liguozhang@ibp.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI080432</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI095097</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494234">IRF7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050839">Interferon Regulatory Factor-7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495371">TLR9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050839" MajorTopicYN="N">Interferon Regulatory Factor-7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051217" MajorTopicYN="N">Toll-Like Receptor 9</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Disclosures</b>. The authors have no financial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25862818</ArticleId><ArticleId IdType="mid">NIHMS689247</ArticleId><ArticleId IdType="pmc">PMC4506778</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1402312</ArticleId><ArticleId IdType="pii">jimmunol.1402312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol. 1989;5:483&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">2557062</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol. 1996;12:575&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">8970738</ArticleId></ArticleIdList></Reference><Reference><Citation>de Duve C. Lysosomes revisited. Eur J Biochem. 1983;137:391&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">6319122</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;der B, Wrocklage C, Pan C, J&#xe4;ger R, K&#xf6;sters B, Sch&#xe4;fer H, Els&#xe4;sser HP, Mann M, Hasilik A. Integral and associated lysosomal membrane proteins. Traffic. 2007;8:1676&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">17897319</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr Opin Immunol. 2002;14:123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">11790542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis V, Green SA, Marsh M, Vihko P, Helenius A, Mellman I. Glycoproteins of the lysosomal membrane. J Cell Biol. 1985;100:1839&#x2013;1847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2113609</ArticleId><ArticleId IdType="pubmed">3922993</ArticleId></ArticleIdList></Reference><Reference><Citation>Barriocanal JG, Bonifacino JS, Yuan L, Sandoval IV. Biosynthesis, glycosylation, movement through the Golgi system, and transport to lysosomes by an N-linked carbohydrate-independent mechanism of three lysosomal integral membrane proteins. J Biol Chem. 1986;261:16755&#x2013;16763.</Citation><ArticleIdList><ArticleId IdType="pubmed">3782140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata S, Fukuda M. Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail. J Biol Chem. 1994;269:5210&#x2013;5217.</Citation><ArticleIdList><ArticleId IdType="pubmed">8106503</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval IV, Arredondo JJ, Alcalde J, Gonzalez Noriega A, Vandekerckhove J, Jimenez MA, Rico M. The residues Leu(Ile) 475-Ile(Leu, Val, Ala)476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes. J Biol Chem. 1994;269:6622&#x2013;6631.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509809</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ning S, Sandoval IV, von Figura K. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3. EMBO J. 1998;17:1304&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170479</ArticleId><ArticleId IdType="pubmed">9482728</ArticleId></ArticleIdList></Reference><Reference><Citation>Janvier K, Kato Y, Boehm M, Rose JR, Martina JA, Kim BY, Venkatesan S, Bonifacino JS. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes. J Cell Biol. 2003;163:1281&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173715</ArticleId><ArticleId IdType="pubmed">14691137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002;115:4117&#x2013;4131.</Citation><ArticleIdList><ArticleId IdType="pubmed">12356916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco-Mar&#xed;n E, Fern&#xe1;ndez-Prieto L, Rodriguez-Del Rio E, Madrazo-Toca F, Reinheckel T, Saftig P, Alvarez-Dominguez C. LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation. J Biol Chem. 2011;286:3332&#x2013;3341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030339</ArticleId><ArticleId IdType="pubmed">21123180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, Hatano T, Furuyama A, Hirota Y, Masuyama N, Saftig P, Himeno M, Fujita H, Tanaka Y. The NH(2)-terminal transmembrane and lumenal domains of LGP85 are needed for the formation of enlarged endosomes/lysosomes. Traffic. 2005;6:895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">16138903</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, Schwake M, Schr&#xf6;der J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007;131:770&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87:3335&#x2013;3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86:5686&#x2013;5696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranova IN, Vishnyakova TG, Bocharov AV, Leelahavanichkul A, Kurlander R, Chen Z, Souza AC, Yuen PS, Star RA, Csako G, et al. Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60. J Immunol. 2012;188:1371&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098944</ArticleId><ArticleId IdType="pubmed">22205027</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">15771572</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselin-Paturel C, Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med. 2005;202:461&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212850</ArticleId><ArticleId IdType="pubmed">16103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006;7:49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">16341217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui R, Saitoh S, Kanno A, Onji M, Shibata T, Ito A, Onji M, Matsumoto M, Akira S, Yoshida N, Miyake K. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity. 2011;35:69&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21683627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature. 2008;452:234&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305481</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui R, Saitoh S, Matsumoto F, Kozuka-Hata H, Oyama M, Tabeta K, Beutler B, Miyake K. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med. 2009;206:1339&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715051</ArticleId><ArticleId IdType="pubmed">19451267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife. 2013;2:e00291. Available at:  http://elifesciences.org/content/2/e00291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3576711</ArticleId><ArticleId IdType="pubmed">23426999</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasai M, Linehan MM, Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science. 2010;329:1530&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063333</ArticleId><ArticleId IdType="pubmed">20847273</ArticleId></ArticleIdList></Reference><Reference><Citation>Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol. 2008;9:1407&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735466</ArticleId><ArticleId IdType="pubmed">18931679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Dum&#xe9;nil AM, Amigorena S, Cabanie L, Manoury B. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity. 2009;31:737&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">19879164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003;170:4465&#x2013;4474.</Citation><ArticleIdList><ArticleId IdType="pubmed">12707322</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med. 2006;203:1999&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118381</ArticleId><ArticleId IdType="pubmed">16864658</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H, Ohara O, Akira S, Kaisho T. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature. 2006;440:949&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">16612387</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 2005;434:1035&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pubmed">15815647</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">15800576</ArticleId></ArticleIdList></Reference><Reference><Citation>Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity. 2008;29:352&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">18799143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaperot L, Perrot I, Jacob MC, Blanchard D, Salaun V, Deneys V, Lebecque S, Bri&#xe8;re F, Bensa JC, Plumas J. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol. 2004;34:418&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">14768046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulcahy JV, Riddell DR, Owen JS. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochem J. 2004;377:741&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1223905</ArticleId><ArticleId IdType="pubmed">14570588</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauls E, Shpiro N, Peggie M, Young ER, Sorcek RJ, Tan L, Choi HG, Cohen P. Essential role for IKK&#x3b2; in production of type 1 interferons by plasmacytoid dendritic cells. J Biol Chem. 2012;287:19216&#x2013;19228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3365954</ArticleId><ArticleId IdType="pubmed">22511786</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domizio J, Blum A, Gallagher-Gambarelli M, Molens JP, Chaperot L, Plumas J. TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. Blood. 2009;114:1794&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847942</ArticleId><ArticleId IdType="pubmed">19553637</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006;25:349&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">16979567</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006;6:644&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">16932750</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Borgne R, Alconada A, Bauer U, Hoflack B. The mammalian AP-3 adaptor-like complex mediates the intracellular transport of lysosomal membrane glycoproteins. J Biol Chem. 1998;273:29451&#x2013;29461.</Citation><ArticleIdList><ArticleId IdType="pubmed">9792650</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamp AC, Tanaka Y, L&#xfc;llmann-Rauch R, Wittke D, D&#x2019;Hooge R, De Deyn PP, Moser T, Maier H, Hartmann D, Reiss K, et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet. 2003;12:631&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620969</ArticleId></ArticleIdList></Reference><Reference><Citation>Knipper M, Claussen C, R&#xfc;ttiger L, Zimmermann U, L&#xfc;llmann-Rauch R, Eskelinen EL, Schr&#xf6;der J, Schwake M, Saftig P. Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis. J Physiol. 2006;576:73&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1995639</ArticleId><ArticleId IdType="pubmed">16901941</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5:1219&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">15549123</ArticleId></ArticleIdList></Reference><Reference><Citation>Krutzik SR, Sieling PA, Modlin RL. The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol. 2001;13:104&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">11154925</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006;6:823&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097510</ArticleId><ArticleId IdType="pubmed">17063184</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004;5:190&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">14716310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantegazza AR, Guttentag SH, El-Benna J, Sasai M, Iwasaki A, Shen H, Laufer TM, Marks MS. Adaptor protein-3 in dendritic cells facilitates phagosomal Toll-like receptor signaling and antigen presentation to CD4(+) T cells. Immunity. 2012;36:782&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361531</ArticleId><ArticleId IdType="pubmed">22560444</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks JC, Sun W, Chiosis G, Leifer CA. Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability. Biochem Biophys Res Commun. 2012;421:780&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358552</ArticleId><ArticleId IdType="pubmed">22554506</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro SM, Falc&#xf3;n-P&#xe9;rez JM, Tenza D, Setty SR, Marks MS, Raposo G, Dell&#x2019;Angelica EC. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol Biol Cell. 2006;17:4027&#x2013;4038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1593172</ArticleId><ArticleId IdType="pubmed">16837549</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, Lin P, Ross C, Li X, Smart NG, Beutler B. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci USA. 2010;107:19973&#x2013;19978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993408</ArticleId><ArticleId IdType="pubmed">21045126</ArticleId></ArticleIdList></Reference><Reference><Citation>Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJ. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Cell Res. 2012;22:1129&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391020</ArticleId><ArticleId IdType="pubmed">22453241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005;23:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16039576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, He B. Recognition of herpes simplex viruses: Toll-like receptors and beyond. J Mol Biol. 2014;426:1133&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943799</ArticleId><ArticleId IdType="pubmed">24262390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Z&#xe4;hringer U, Beutler B. CD36 is a sensor of diacylglycerides. Nature. 2005;433:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">15690042</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem. 2006;281:31002&#x2013;31011.</Citation><ArticleIdList><ArticleId IdType="pubmed">16880211</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11:155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2809046</ArticleId><ArticleId IdType="pubmed">20037584</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bl&#xfc;ml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyavsky M, et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010;207:2689&#x2013;2701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989773</ArticleId><ArticleId IdType="pubmed">21078886</ArticleId></ArticleIdList></Reference><Reference><Citation>Braudeau C, Graveleau J, Rimbert M, N&#xe9;el A, Hamidou M, Grosbois B, Besan&#xe7;on A, Giraudet S, Terrien C, Josien R, Masseau A. Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease. Blood Cells Mol Dis. 2013;50:281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">23357793</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler E. Gaucher disease: multiple lessons from a single gene disorder. Acta Paediatr Suppl. 2006;95:103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">16720474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibbens LM, Karakis I, Bayly MA, Costello DJ, Cole AJ, Berkovic SF. Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy. Arch Neurol. 2011;68:812&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">21670406</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayati A, DePaolo J, Gupta N, Choi JH, Moaven N, Westbroek W, Goker-Alpan O, Goldin E, Stubblefield BK, Kolodny E, et al. A mutation in SCARB2 is a modifier in Gaucher disease. Hum Mutat. 2011;32:1232&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196787</ArticleId><ArticleId IdType="pubmed">21796727</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">17979852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>